An evaluation of intravenous, subcutaneous, and in vitro activity of new agmatine analogs of growth hormone-releasing hormone hGH-RH(1–29)NH2
- 1 January 1988
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 42 (1) , 27-35
- https://doi.org/10.1016/0024-3205(88)90621-2
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Strategies in the design of synthetic agonists and antagonists of growth hormone releasing factorPeptides, 1986
- Growth hormone responses to growth hormone-releasing hormine (1–29)-NH2 and a D-Ala2 analog in normal menPeptides, 1985
- Growth induced by pulsatile infusion of an amidated fragment of human growth hormone releasing factor in normal and GHRF-deficient ratsNature, 1985
- Structure-activity studies on the N-terminal region of growth hormone releasing factorJournal of Medicinal Chemistry, 1985
- An Extremely Sensitivein VitroModel for Elucidating Structure-Activity Relationships of Growth Hormone-Releasing Factor Analogs*Endocrinology, 1985
- Synthesis and invitro bioactivity of C-terminal deleted analogs of human growth hormone-releasing factorBiochemical and Biophysical Research Communications, 1984
- RESPONSES TO ANALOGUES OF GROWTH HORMONE-RELEASING HORMONE IN NORMAL SUBJECTS, AND IN GROWTH-HORMONE DEFICIENT CHILDREN AND YOUNG ADULTSClinical Endocrinology, 1984
- Growth hormone releasing factor: comparison of two analogues and demonstration of hypothalamic defect in growth hormone release after radiotherapy.BMJ, 1984
- Super-active analogs of growth hormone-releasing factor (1–29)-amideBiochemical and Biophysical Research Communications, 1984
- Invivo biological potency of rat and human growth hormone-releasing factor and fragments of human growth hormone-releasing factorBiochemical and Biophysical Research Communications, 1983